Financial toxicity in patients with lung cancer: a scoping review protocol.

ABSTRACT:

Introduction

Lung cancer has the second-ranked morbidity rate and the first-ranked mortality rate worldwide. With the progression of the cancer condition and the advancement of new treatments, the corresponding medical expenses have risen sharply. Nowadays, financial toxicity has become one of the most common concerns in patients with cancer. However, by far, the full landscape of studies on financial toxicity is unclear in patients with lung cancer. Thus, this scoping review aims to summarise the degree, affecting factors, outcomes and intervention strategies of financial toxicity in patients with lung cancer.

Methods and analysis

This scoping review will be developed following the methodology described in the Joanna Briggs Institute Manual for Evidence Synthesis on scoping

SUBMITTER: Fu L 

PROVIDER: S-EPMC9131061 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature